Drug
Ro7830698
Ro7830698: highest development phase Phase 1/2, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| RO7830698 NCT07822334 | Phase 1/2 | Chronic Obstructive Pulmonary Disease (COPD) |
Latest
No recent events.
Follow Ro7830698 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.